AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Health Canada gives approval to begin field trial of FluINsure.
2003 NOV 12 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced that it has received a "No Objection" letter from Health Canada conveying approval to begin its scheduled field study of FluINsure trivalent influenza vaccine, a nonliving vaccine for intranasal administration.
In addition, Health Canada has provided lot release for all of the test articles to be used in the trial, which allows administration of the vaccine to begin. Screening of potential subjects and shipments of study vaccine are underway.
The 2003 "in-season" field trial is being conducted at approximately 25 sites across Canada, and is planned to enroll a target of 1320 healthy adult subjects, 18-64 years of age.
Subjects will be assigned randomly, with stratification on age and receipt of influenza vaccine in the prior two seasons, to one of three ...
- ID Biomedical Announces Positive Results from Phase II Clinical Trial of...
- Press release article from: PR Newswire August 10, 2004 700+ words
...IDBE", TSX - "IDB" ID Biomedical announced today that a preliminary...trials, will be used by ID Biomedical to approach Health Canada and the U.S. Food and...Chief Executive Officer of ID Biomedical. "The critical roadblock...
- ID Biomedical wins government contract for meningitis C vaccine.
- Press release article from: PR Newswire September 13, 2004 700+ words
...years of the contract. "ID Biomedical is committed to participate...regimen. On May 5, 2004, ID Biomedical received the approval from Health Canada of a new NeisVac-C two...marketing in this country. ID Biomedical has obtained exclusive...
- ID Biomedical Provides Update on Vaccine Development Programs.
- Press release article from: PR Newswire October 24, 2005 700+ words
...PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX...streptococcal diseases. ID Biomedical announced that it has obtained clearance from Health Canada to begin the first...children. At this time, ID Biomedical is not able to precisely...
- ID Biomedical begins trivalent nasal flu vaccine study; FluINsure(TM) is...
- Press release article from: PR Newswire December 20, 2001 700+ words
...20 /PRNewswire/ - ID Biomedical announced today that...received permission from Health Canada to proceed with the...Regulatory Affairs for ID Biomedical said, "In this trial...against the virus. ID Biomedical's flu vaccine is...
- ID Biomedical receives approval to begin field trial of FluINsure; TRADING...
- Press release article from: PR Newswire October 16, 2003 700+ words
ID Biomedical announced today that it has received a "No Objection" letter from Health Canada conveying approval to begin its scheduled...occur in April and May of 2004. About ID Biomedical ID Biomedical is a biotechnology company...
- ID Biomedical begins trivalent nasal flu vaccine study.(Vaccine for prevention...
- Newspaper article from: BIOTECH Patent News December 1, 2001 700+ words
ID Biomedical Corporation (Vancouver...received permission from Health Canada to proceed with the...Regulatory Affairs for ID Biomedical said, "In this trial...against the virus. ID Biomedical's flu vaccine is based...
- ID Biomedical files I.N.D. for nasal flu vaccine trial.
- Press release article from: PR Newswire November 13, 2001 700+ words
...13 /PRNewswire/ - ID Biomedical announced today that...Therapeutics Directorate of Health Canada to conduct a Phase...Dr. Louis Fries, ID Biomedical's VP of Clinical...a single dose." ID Biomedical's flu vaccine is...
- ID Biomedical announces distribution of its influenza vaccine, Fluviral.
- Press release article from: PR Newswire September 10, 2004 700+ words
ID Biomedical Corporation (TSX...regulatory clearance from Health Canada. This release will...2004-2005 season. ID Biomedical expects to ship between...Canadian public market. "ID Biomedical is committed to growing...
Source: HighBeam Research, Health Canada gives approval to begin field trial of FluINsure.